Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Stoppen met nucleos(t)ide-analogen bij HBeAg-negatieve chronische hepatitis B?
aug 2023 | Hepatitis, Hepatologie